Brief: Natco Pharma Says Natco Pharma (Canada) Inc. Announces $8 Mln Investment In Egenesis, Inc
04/09/2024 06:39
Sept 4 (Reuters) - Natco Pharma Ltd NATP.NS :
* NATCO PHARMA (CANADA) INC. ANNOUNCES US$ 8 MILLION
INVESTMENT IN
EGENESIS, INC.
Source text for Eikon: ID:nBSE8sm9WY
Further company coverage: NATP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees